Vanta Bioscience Complete Financial Statements
VANTABIO • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Vanta Bioscience (VANTABIO).
Downloads include all available records across all periods.
For market performance, see the
VANTABIO stock price today
.
Profitability Ratios
Net Profit Margin
-100.00%
2023 data
EBITDA Margin
-100.00%
2023 data
Operating Margin
-206.00%
2023 data
Return on Assets
-1.16%
2023 data
Return on Equity
-25.00%
2023 data
Balance Sheet Ratios
Current Ratio
0.27
2023 data
Debt to Equity
21.50
2023 data
Equity Ratio
4.65%
2023 data
Asset Turnover
0.01
2023 data
Year-over-Year Growth Analysis
Comparing Mar 2022 vs Mar 2023
Revenue Growth
-80.0%
Year-over-Year
EBITDA Growth
-150.0%
Year-over-Year
Assets Growth
+1.2%
Year-over-Year
Equity Growth
-69.2%
Year-over-Year
Liabilities Growth
+1.2%
Year-over-Year
Operating Cash Flow Growth
-166.7%
Year-over-Year
Investing Cash Flow Growth
-133.3%
Year-over-Year
Financing Cash Flow Growth
+800.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Mar 2023 | Mar 2022 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|
| Revenue | 1 | 5 | 3 | 0 |
| Expenses | 2 | 2 | 3 | 0 |
| EBITDA | -1 | 2 | -1 | 0 |
| Operating Profit Margin % | -206.00% | 46.00% | -20.00% | 0.00% |
| Depreciation | 0 | 1 | 1 | 0 |
| Interest | 1 | 1 | 3 | 0 |
| Profit Before Tax | -2 | 1 | -4 | 0 |
| Tax | 0 | 0 | -2 | 0 |
| Net Profit | -1 | 0 | -3 | 0 |
| Earnings Per Share (₹) | 0.00 | 0.11 | -4.06 | 0.00 |
Related Pages for Vanta Bioscience
Additional stock information and data for VANTABIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 86 | 85 | 85 | 81 | 70 | 49 | 39 |
| Current Assets | 15 | 17 | 15 | 15 | 20 | 20 | 17 |
| Fixed Assets | 56 | 54 | 57 | 36 | 29 | 21 | 18 |
| Capital Work in Progress | 14 | 13 | 11 | 29 | 19 | 7 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 17 | 19 | 17 | 17 | 21 | 21 | 16 |
| LIABILITIES | |||||||
| Total Liabilities | 86 | 85 | 85 | 81 | 70 | 49 | 39 |
| Current Liabilities | 56 | 50 | 48 | 34 | 29 | 14 | 13 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 4 | 13 | 19 | 29 | 26 | 25 | 23 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 4 | 9 | 11 | 18 | 18 | 17 | 16 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 3 | -1 | 5 | 7 | 2 | -1 |
| Investing Activities | -7 | -3 | -6 | -17 | -22 | -8 | -6 |
| Financing Activities | 9 | 1 | 6 | 10 | 18 | 2 | 10 |
| Net Cash Flow | 0 | 0 | 0 | -2 | 3 | -3 | 3 |